XML 69 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Stock Option Plans) (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 29, 2019
Feb. 29, 2020
Jun. 30, 2020
Jun. 30, 2020
Jan. 01, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]          
Weighted average grant date fair value, vested     $ 100 $ 200  
Weighted average remaining contractual term, outstanding       5 years 4 days  
Weighted average remaining contractual term, vested and exercisable       3 years 11 months 9 days  
Stock options          
Number of Options          
Balance outstanding at the beginning of the period (in shares)       1,802,463  
Granted (in shares)       191,667  
Expired (in shares)       (351,938)  
Balance outstanding at the end of the period (in shares)     1,642,192 1,642,192  
Total vested and exercisable (in shares)     1,269,509 1,269,509  
Weighted Average Exercise Price per Share          
Balance at the beginning of the period (in dollars per share)       $ 6.75  
Granted (in dollars per share)       0.98  
Expired (in dollars per share)       7.91  
Balance at the end of the period (in dollars per share)     $ 5.83 5.83  
Total vested and exercisable (in dollars per share)     $ 6.75 $ 6.75  
Aggregate Intrinsic Value (in Thousands)          
Outstanding at end of the period     $ 0 $ 0  
Total vested and exercisable     0 0  
Restricted stock awards          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]          
Weighted average grant date fair value, vested     $ 1,400 $ 1,800  
Number of Shares          
Unvested beginning of period (in shares)       4,436,928  
Granted (in shares)       3,927,355  
Vested (in shares)       (1,148,503)  
Forfeited (in shares)       (191,193)  
Unvested end of period (in shares)     7,024,587 7,024,587  
Weighted Average Fair Value          
Unvested beginning of period (in dollars per share)       $ 1.54  
Granted (in dollars per share)       0.98  
Vested (in dollars per share)       1.57  
Forfeited (in dollars per share)       1.25  
Unvested end of period (in dollars per share)     $ 1.24 $ 1.24  
2015 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common stock available for future issuance (in shares)     300,869 300,869  
Additional shares authorized, maximum annual amount (in shares)     3,000,000 3,000,000 2,112,822
Additional shares authorized, maximum annual percentage     3.00% 3.00%  
2019 Sales Team Plan | Common Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized (in shares) 3,000,000        
Award expiration period 10 years        
Number of Shares          
Unvested end of period (in shares)     2,756,481 2,756,481  
Chief Financial Officer | Restricted stock awards          
Number of Shares          
Granted (in shares)   125,000      
Chief Financial Officer | Inducement Award [Member]          
Number of Options          
Granted (in shares)   125,000      
Weighted Average Exercise Price per Share          
Granted (in dollars per share)   $ 0.98      
Senior Vice President, Operations | Restricted stock awards          
Number of Shares          
Granted (in shares)   61,350      
Senior Vice President, Operations | Inducement Award [Member]          
Number of Options          
Granted (in shares)   66,667      
Weighted Average Exercise Price per Share          
Granted (in dollars per share)   $ 0.98